Researchers discovered that digested SARS-CoV-2 spike protein fragments selectively attack certain immune cells, reducing ...
A new hypothesis article was published in Oncotarget (Volume 17) on January 3, 2026, titled “Hypothesis: HPV E6 and COVID spike proteins cooperate in targeting tumor suppression by p53.” ...
BURTON, MI, UNITED STATES, January 9, 2026 /EINPresswire.com/ -- Javelin Sciences, a pioneering certified biotechnology ...
Key takeawaysA UCLA-led research team demonstrated that when human immune enzymes break up the spike protein of the virus ...
Phase 2 clinical trial will evaluate the safety, translational biology, and exploratory clinical efficacy of VYD2311 in people with Long COVID or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results